Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ben-Rafael, Z.
Right arrow Articles by Orvieto, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ben-Rafael, Z.
Right arrow Articles by Orvieto, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol 13, 1470-1471, Copyright © 1998 by Oxford University Press

ARTICLES

Simplifying ovulation induction for surrogacy in women with Mayer- Rokitansky-Kuster-Hauser syndrome

Z Ben-Rafael, I Bar-Hava, T Levy and R Orvieto
Department of Obstetrics and Gynecology, Rabin Medical Center, Petah Tikva, Israel.

A simple approach for ovulation induction in women with Mayer- Rokitansky-Kuster-Hauser Syndrome (MRKH-S) during in-vitro fertilization (IVF)/freezing/surrogacy cycles was evaluated. Weekly progesterone plasma concentrations were measured in order to accurately establish the luteal phase in MRKH-S women. When a rising titre was detected, a gonadotrophin-releasing hormone analogue (GnRHa) was administered as part of a long protocol. Two weeks later human menopausal gonadotrophin (HMG) therapy was started. Ten treatment cycles in four women with MRKH-S were carried out. In all cases, three or less progesterone estimations were needed. Three of the four women are now, through surrogacy, genetic mothers; one of them has two children. We concluded that weekly determination of progesterone plasma concentration is a convenient, efficient and inexpensive simple approach to identify the luteal phase, and therefore suitable to the start of a GnRHa/HMG protocol in MRKH-S women enrolled in an assisted reproduction technology programme.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
J. M. Goldfarb, C. Austin, B. Peskin, H. Lisbona, N. Desai, and J.R. L. de Mola
Fifteen years experience with an in-vitro fertilization surrogate gestational pregnancy programme
Hum. Reprod., May 1, 2000; 15(5): 1075 - 1078.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
E. G. Wood, F. R. Batzer, and S. L. Corson
Ovarian response to gonadotrophins, optimal method for oocyte retrieval and pregnancy outcome in patients with vaginal agenesis
Hum. Reprod., May 1, 1999; 14(5): 1178 - 1181.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
O.B.A. den van Akker
Organizational selection and assessment of women entering a surrogacy agreement in the UK
Hum. Reprod., January 1, 1999; 14(1): 262 - 266.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.